Daniel Woolson - 06 Mar 2022 Form 4 Insider Report for ICU MEDICAL INC/DE (ICUI)

Role: VP, GM-Infusion Capital
Signature: By: Paula Darbyshire, Attorney-in-fact For: Daniel Woolson
Issuer symbol: ICUI
Transactions as of: 06 Mar 2022
Net transactions value: -$155,232
Form type: 4
Filing time: 08 Mar 2022, 18:23:56 UTC
Next filing: 02 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ICUI	Common Stock	Options Exercise	$0	+1,444	+18%	$0.000000	9,606	06 Mar 2022	Direct	F1
transaction	ICUI	Common Stock	Tax liability	$155,232	-639	-6.7%	$242.93	8,967	06 Mar 2022	Direct
transaction	ICUI	Common Stock	Options Exercise	$0	+1,418	+16%	$0.000000	10,385	06 Mar 2022	Direct	F1
transaction	ICUI	Common Stock	Tax liability	$0	-628	-6%	$0.000000	9,757	06 Mar 2022	Direct	F2
transaction	ICUI	Common Stock	Options Exercise	$0	+2,020	+21%	$0.000000	11,777	08 Mar 2022	Direct	F1
transaction	ICUI	Common Stock	Tax liability	$0	-894	-7.6%	$0.000000	10,883	08 Mar 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ICUI	Common Stock	Award	$0	+2,897		$0.000000	2,897	07 Mar 2022	Common Stock	2,897	$0.000000	Direct	F2, F3, F4, F5
transaction	ICUI	Common Stock	Options Exercise	$0	-1,444	-100%	$0.000000^*	0	06 Mar 2022	Common Stock	1,444		Direct	F1, F6, F7
transaction	ICUI	Performance Shares	Options Exercise	$0	-2,020	-33%	$0.000000	4,040	08 Mar 2022	Common Stock	2,020	$0.000000	Direct	F1, F6, F8
transaction	ICUI	Performance Shares	Options Exercise	$0	-1,418	-50%	$0.000000	1,417	06 Mar 2022	Common Stock	1,418		Direct	F1, F6, F9

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These Securities are Performance-based Restricted Stock Units (PRSU).
F2	These securities are Restricted Stock Units.
F3	There is neither a purchase price nor an exercise price for the Restricted Stock Units.
F4	One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.
F5	These are restricted stock units that fully vest 3 years from the grant date.
F6	There is neither a purchase price nor an exercise price for the PRSUs.
F7	These PRSUs were granted on March 6, 2019. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on March 6 of the first, second, and third year following the year of grant.
F8	These PRSUs were granted on March 6, 2021. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on March 6 of the first, second, and third year following the year of grant.
F9	These PRSUs were granted on March 6, 2020. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on March 6 of the first, second, and third year following the year of grant.